Trifluridine and Tipiracil (Lonsurf®) + Bevacizumab for the Treatment of Metastatic Colorectal Cancer

This PQI in Action is a follow up to the Trifluridine and Tipiracil (Lonsurf®) for Metastatic Colorectal Cancer PQI and explores how the medically integrated teams at Baptist MD Anderson Cancer Center and University of Illinois Cancer Center collaborate and utilize the information found in the PQI as part of their daily practice. This PQI in Action focuses on the use of Lonsurf in combination with bevacizumab to optimize the treatment of patients with previously treated metastatic colorectal cancer (CRC).